Leprosy Mailing List – March 10, 2021
Ref.: (LML) d.d. pure neuritic leprosy and diabetic neuropathy
From: Eric L. Wan, Potamec, USA
___________________________________________________________________
Dear Pieter and colleagues,
I would like to provide some additional information regarding outcomes following the neuroplasties / neurolysis / nerve decompression in Hansen's Disease as alluded to by Dr. Wilton and Dr. Theuvenet. Attached, you will find our long-term outcome study results published in Leprosy Review in 2017. You can also find it here: https://leprosyreview.org/article/88/1/09-5108
Furthermore, in that same year, we devised a thoughtful (managerially and statistically speaking) multi-center randomized-controlled trial at Johns Hopkins and collaborating institutions to provide high-quality evidence regarding the effects of nerve decompression in the context of Hansen's Disease. Included in our proposal was funding for local country staff coordinators and a variety of outcome measures.
We were unable to secure funding at that time; however, we are open to additional collaboration and insight on potential funding leads. Our collaborators represent Hansen's Disease organizations in several countries, including: Brazil, Colombia, Ecuador, India, Nepal, Netherlands, and USA.
Many thanks for your time and collegiality,
Eric
Eric L. Wan, MPH MBA
Cell: (240) 899 1181
___________________________________________________________________
LML - S Deepak, B Naafs, S Noto and P Schreuder
LML blog link: http://leprosymailinglist.blogspot.it/
Contact: Dr Pieter Schreuder << edit...@gmail.com
--You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/be7cef63-5b35-480a-87da-351d5f85bb73n%40googlegroups.com.
No comments:
Post a Comment